Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neonatology

  Free Subscription


Articles published in Pediatr Pulmonol

Retrieve available abstracts of 249 articles:
HTML format



Single Articles


    October 2022
  1. WILSON LM, Potter A, Maher C, Ellis MJ, et al
    Feasibility of the A-STEP for the assessment of exercise capacity in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2524-2532.
    PubMed     Abstract available


  2. SHANTHIKUMAR S, Ranganathan S, Neeland MR
    Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2549-2552.
    PubMed    


  3. NASR SZ, Gokdemir Y, Erdem E, Karakoc F, et al
    Collaboration between two CF centers; one in USA and one in Turkey before and during CoV2 pandemic.
    Pediatr Pulmonol. 2022;57:2553-2557.
    PubMed     Abstract available


  4. HUANG L, Lai HJ, Antos N, Rock MJ, et al
    Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics.
    Pediatr Pulmonol. 2022;57:2363-2373.
    PubMed     Abstract available


  5. GUR M, Zuckerman-Levin N, Masarweh K, Hanna M, et al
    The effect of probiotic administration on metabolomics and glucose metabolism in CF patients.
    Pediatr Pulmonol. 2022;57:2335-2343.
    PubMed     Abstract available


  6. CHUNG J, Iyengar A, Santry L, Swanson E, et al
    Changes in respiratory management and the impact on bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:2327-2334.
    PubMed     Abstract available


  7. HAMOUDA S, Hadj Fredj S, Messaoud T, Scotet V, et al
    Up-to-date incidence and initial characteristics of cystic fibrosis in Tunisia.
    Pediatr Pulmonol. 2022;57:2540-2541.
    PubMed    


    September 2022
  8. MARCZAK H, Peradzynska J, Lange J, Boguslawski S, et al
    Pulmonary function in children with persistent tachypnea of infancy.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26162.
    PubMed     Abstract available


  9. YONEDA K, Amari S, Mikami M, Uchida K, et al
    Development of Mortality Prediction Models for Infants with Isolated, Left-Sided Congenital Diaphragmatic Hernia Before and After Birth.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26172.
    PubMed     Abstract available


  10. KASNIYA G, Weinberger B, Cerise J, Pulju M, et al
    Lung Ultrasound Assessment of Pulmonary Edema in Neonates with Chronic Lung Disease Before and After Diuretic Therapy.
    Pediatr Pulmonol. 2022 Sep 29. doi: 10.1002/ppul.26150.
    PubMed     Abstract available


  11. MA HR, Deng BY, Liu J, Jiang P, et al
    Lung Ultrasound to Diagnose Infectious Pneumonia of Newborns: A Prospective Multicenter Study.
    Pediatr Pulmonol. 2022 Sep 28. doi: 10.1002/ppul.26168.
    PubMed     Abstract available


  12. LI L, Liu R, Wang Y, Wang W, et al
    Type II Congenital Pulmonary Airway Malformation with Primary Ciliary Dyskinesia in a 4-year-old Child: A Case Report.
    Pediatr Pulmonol. 2022 Sep 27. doi: 10.1002/ppul.26167.
    PubMed     Abstract available


  13. DANAN C, Tauzin M, Jung C, Durrmeyer X, et al
    Humidity during high-frequency oscillatory ventilation compared to intermittent positive pressure ventilation in extremely preterm neonates: An in vitro and in vivo observational study.
    Pediatr Pulmonol. 2022 Sep 14. doi: 10.1002/ppul.26157.
    PubMed     Abstract available


  14. HARRIS C, Morris S, Lunt A, Peacock J, et al
    Influence of bronchopulmonary dysplasia on lung function in adolescents who were born extremely prematurely.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26151.
    PubMed     Abstract available


  15. JANA T, Vaclav K, Daniela M, Petr K, et al
    Symptomatic preterm infants suffer from lung function deficits, regardless of bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26144.
    PubMed     Abstract available


  16. GUDMUNDSDOTTIR HK, Hilde K, Bains KES, Fardig M, et al
    Online supplement for the article: Fetal thoracic circumference in mid-pregnancy and infant lung function.
    Pediatr Pulmonol. 2022 Sep 13. doi: 10.1002/ppul.26153.
    PubMed     Abstract available


  17. HAIDER S, Azhar N, Zahid M, Iqbal K, et al
    Comparative effectiveness of Calfactant and Beractant in Neonatal Respiratory Distress Syndrome: A systemic review and meta-analysis.
    Pediatr Pulmonol. 2022 Sep 12. doi: 10.1002/ppul.26149.
    PubMed     Abstract available


  18. DIGGIKAR S, Paul A, Razak A, Chandrasekaran M, et al
    Respiratory Infections in Children Born Preterm in Low and Middle-income countries - A Systematic Review.
    Pediatr Pulmonol. 2022 Sep 7. doi: 10.1002/ppul.26128.
    PubMed     Abstract available


  19. GIACALONE VD, Moncada-Giraldo D, Margaroli C, Brown MR, et al
    Pilot study of inflammatory biomarkers in matched induced sputum and bronchoalveolar lavage of 2-year-olds with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2189-2198.
    PubMed     Abstract available


  20. JANUSKA MN, Langfelder-Schwind E, Berdella MN
    Overcoming health disparities in access to CFTR modulator therapies: One child's journey with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2273-2275.
    PubMed    


  21. SALVATORE D, Cimino G, Troiani P, Bignamini E, et al
    Elexacaftor/tezacaftor/ivacaftor in children aged 6-11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24-week observational study.
    Pediatr Pulmonol. 2022;57:2253-2256.
    PubMed    


  22. STEINDOR M, Wagner CE, Kavvalou A, Bock C, et al
    Indications and outcome of home high-flow nasal therapy in children, a single-center experience.
    Pediatr Pulmonol. 2022;57:2048-2052.
    PubMed     Abstract available


  23. GIARDINA M, Barilla D, Crimi C, Arone A, et al
    Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:2060-2066.
    PubMed     Abstract available


  24. BANWELL E, Collaco JM, Oates GR, Rice JL, et al
    Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:2053-2059.
    PubMed     Abstract available


    August 2022
  25. SOLIS-GARCIA G, Gonzalez-Pacheco N, Ramos-Navarro C, Vigil-Vazquez S, et al
    Lung recruitment in neonatal high-frequency oscillatory ventilation with volume-guarantee.
    Pediatr Pulmonol. 2022 Aug 22. doi: 10.1002/ppul.26124.
    PubMed     Abstract available


  26. ELDERS BBLJ, Tiddens HAWM, Pijnenburg MWH, Reiss IKM, et al
    Lung structure and function on MRI in preterm born school children with and without BPD: a feasibility study.
    Pediatr Pulmonol. 2022 Aug 18. doi: 10.1002/ppul.26119.
    PubMed     Abstract available


  27. OZAWA Y, Miyake F, Isayama T
    Efficacy and safety of permissive hypercapnia in preterm infants: A systematic review.
    Pediatr Pulmonol. 2022 Aug 9. doi: 10.1002/ppul.26108.
    PubMed     Abstract available


  28. NING J
    A new oxygen therapy support device for infant bronchoscopy?
    Pediatr Pulmonol. 2022 Aug 6. doi: 10.1002/ppul.26105.
    PubMed    


  29. KITAJIMA H, Fujimura M, Takeuchi M, Kawamoto Y, et al
    Intrauterine Ureaplasma is associated with small airway obstruction in extremely preterm infants.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26098.
    PubMed     Abstract available


  30. NASCIMENTO MS, do Prado C, Costa ELV, Alcala GC, et al
    Effect of Flow rate on the end-expiratory lung volume in infants with bronchiolitis using high-flow nasal cannula evaluated through electrical impedance tomography.
    Pediatr Pulmonol. 2022 Aug 5. doi: 10.1002/ppul.26082.
    PubMed     Abstract available


  31. REITER J, Breuer O, Cohen-Cymberknoh M, Forno E, et al
    Sleep in children with cystic fibrosis: More under the covers.
    Pediatr Pulmonol. 2022;57:1944-1951.
    PubMed     Abstract available


    July 2022
  32. ONG JWY, Everitt L, Hiscutt J, Griffiths C, et al
    Characteristics and outcome of infants with bronchopulmonary dysplasia established on long-term ventilation from neonatal intensive care.
    Pediatr Pulmonol. 2022 Jul 19. doi: 10.1002/ppul.26072.
    PubMed     Abstract available


  33. HOUSE M, Klein S, Parham D, Hysinger EB, et al
    Frequent hypoxemia found in infants with bronchopulmonary dysplasia after weaning home oxygen.
    Pediatr Pulmonol. 2022 Jul 13. doi: 10.1002/ppul.26076.
    PubMed     Abstract available


  34. REN CL, Slaven JE, Haas DM, Haneline LS, et al
    Forced Expiratory Flows and Diffusion Capacity in Infants Born from Mothers with Pre-eclampsia.
    Pediatr Pulmonol. 2022 Jul 7. doi: 10.1002/ppul.26064.
    PubMed     Abstract available


  35. BUENDIA JA, Patino DG, Lindarte EF
    Vitamin A supplementation for the prevention of chronic lung disease in premature infants: a cost-utility analysis.
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26067.
    PubMed     Abstract available


  36. RODRIGUEZ-FANJUL J, Corsini I, Ortiz CS, Bobillo-Perez S, et al
    Lung ultrasound to evaluate lung recruitment in neonates with respiratory distress (RELUS study).
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26066.
    PubMed     Abstract available


  37. GALVIS C, Colmenares A, Cabrales L, Ibata L, et al
    Impact of immunoprophylaxis with palivizumab on respiratory syncytial virus infection in preterm infants less than 35 weeks in Colombian hospitals.
    Pediatr Pulmonol. 2022 Jul 6. doi: 10.1002/ppul.26051.
    PubMed     Abstract available


  38. EGALA A, Hariharan R, Sarangarajan S, Puntambekar A, et al
    An uncommon cause of spontaneous pneumothorax in a febrile infant: Atypical Kawasaki Disease.
    Pediatr Pulmonol. 2022 Jul 5. doi: 10.1002/ppul.26062.
    PubMed     Abstract available


  39. DRISCOLL S, Carroll WD, Nichani S, Fishwick R, et al
    COVID-19 infection and nocardiosis causing the death of an adolescent with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1823-1825.
    PubMed    


  40. SAVANT AP
    Cystic fibrosis year in review 2021.
    Pediatr Pulmonol. 2022;57:1590-1599.
    PubMed     Abstract available


  41. THAVAMANI A, Umapathi KK, Kutney K, Sferra TJ, et al
    Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1717-1725.
    PubMed     Abstract available


  42. MCKINZIE CJ, Kam CW, Parry R, Darby M, et al
    Pharmacist-administered audiology screening for pediatric cystic fibrosis patients exposed to high-dose aminoglycosides: A pilot study.
    Pediatr Pulmonol. 2022;57:1814-1817.
    PubMed     Abstract available


  43. MOLLER R, Nielsen BU, Faurholt-Jepsen D, Katzenstein TL, et al
    Use of inhaled antibiotics among Danish patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1726-1734.
    PubMed     Abstract available


  44. ALLAER L, Lejeune S, Mordacq C, Deschildre A, et al
    Primary ciliary dyskinesia and fungal infections: Two cases of allergic bronchopulmonary aspergillosis in children.
    Pediatr Pulmonol. 2022;57:1809-1813.
    PubMed     Abstract available


  45. COLLACO JM, Tracy MC, Sheils CA, Rice JL, et al
    Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022;57:1735-1743.
    PubMed     Abstract available


  46. BOUZEK DC, Ren CL, Thompson M, Slaven JE, et al
    Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1709-1716.
    PubMed     Abstract available


  47. MUIRHEAD C, Verzasconi D, Joshi S
    At-home compounding preparation of slow desensitization of elexacaftor/tezacaftor/ivacaftor for delayed hypersensitivity rash.
    Pediatr Pulmonol. 2022;57:1779-1781.
    PubMed     Abstract available


    June 2022
  48. AUER-HACKENBERG L, Stroicz P, Hofstatter E, Brandner J, et al
    Breath-dependent pressure fluctuations in various constant- and variable-flow neonatal CPAP devices.
    Pediatr Pulmonol. 2022 Jun 30. doi: 10.1002/ppul.26050.
    PubMed     Abstract available


  49. RAO P, Charki S, Aradhya AS, Diggikar S, et al
    Prediction score for prolonged hospital stay in Meconium aspiration syndrome: A Multicentric collaborative cohort of South India.
    Pediatr Pulmonol. 2022 Jun 27. doi: 10.1002/ppul.26044.
    PubMed     Abstract available


  50. RUB DM, Sivieri EM, Abbasi S, Sieberlich W, et al
    Comparison of Nasal Intermittent Positive Pressure Ventilation and Bubble CPAP with an In-Line High Frequency Interrupter in a Premature Infant Lung Model.
    Pediatr Pulmonol. 2022 Jun 20. doi: 10.1002/ppul.26039.
    PubMed     Abstract available


  51. KURUMA K, Otomo T, Sakama T, Akiyama K, et al
    Breath sound analyses of infants with respiratory syncytial virus acute bronchiolitis.
    Pediatr Pulmonol. 2022 Jun 7. doi: 10.1002/ppul.26034.
    PubMed     Abstract available


  52. ALESSANDRO P, Annamaria S, Letizia PM, Stefano N, et al
    Early lung ultrasound score to predict non-invasive ventilation needing in neonates from 33 weeks of gestational age: a multi-centric study.
    Pediatr Pulmonol. 2022 Jun 6. doi: 10.1002/ppul.26031.
    PubMed     Abstract available


  53. ENZER KG, Wine TM, Gien J, Somme S, et al
    Posterior tracheopexy for preterm infants with severe bronchopulmonary dysplasia and severe tracheobronchomalacia: A case series.
    Pediatr Pulmonol. 2022 Jun 4. doi: 10.1002/ppul.26029.
    PubMed     Abstract available


  54. ARMERO G, Penela-Sanchez D, Belmonte J, Gomez-Barroso D, et al
    Concentrations of nitrogen compounds are related to severe rhinovirus infection in infants. A time-series analysis from the reference area of a pediatric university hospital in Barcelona.
    Pediatr Pulmonol. 2022 Jun 2. doi: 10.1002/ppul.26021.
    PubMed     Abstract available


  55. ABDELMAWLA M, Seleem W, Farooqui M, Eltayeb A, et al
    Prediction of Weaning Readiness off Nasal CPAP in Preterm Infants Using Point-of-Care Lung Ultrasound.
    Pediatr Pulmonol. 2022 Jun 2. doi: 10.1002/ppul.26014.
    PubMed     Abstract available


  56. MELLOR X, Schindler T, Saab S, Roesch E, et al
    Eosinophilic esophagitis in cystic fibrosis: A case series with long-term follow-up.
    Pediatr Pulmonol. 2022;57:1557-1561.
    PubMed     Abstract available


  57. ISRAELI T, Eisenstadt I, Shoseyov D, Armoni S, et al
    Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis.
    Pediatr Pulmonol. 2022;57:1552-1554.
    PubMed     Abstract available


  58. XUEREB J, Sammut P, Vella C, Balfour-Lynn IM, et al
    Resolution of lobe collapse in a child with cystic fibrosis with Mycobacterium abscessus using serial intrabronchial rhDNase.
    Pediatr Pulmonol. 2022;57:1549-1551.
    PubMed     Abstract available


  59. YUAN Y, Yang Y, Lei X, Dong W, et al
    Caffeine and bronchopulmonary dysplasia: Clinical benefits and the mechanisms involved.
    Pediatr Pulmonol. 2022;57:1392-1400.
    PubMed     Abstract available


  60. WOJSYK-BANASZAK I, Wieckowska B, Stachowiak Z, Kycler M, et al
    Predictive value of impulse oscillometry and multiple breath washout parameters in pediatric patients with cystic fibrosis pulmonary exacerbation.
    Pediatr Pulmonol. 2022;57:1466-1474.
    PubMed     Abstract available


  61. MARPOLE R, Wilson AC
    Benefits of reviewing pancreatic function in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1537-1539.
    PubMed    


  62. MCKINZIE CJ, Hagood JS, Fiorino EK, Fishman MP, et al
    The role of pharmacy services beyond cystic fibrosis: A case for support in childhood interstitial lung disease.
    Pediatr Pulmonol. 2022;57:1535-1536.
    PubMed    


  63. MELICOFF E, Ruiz FE, Hosek K, Mallory GB, et al
    Cystic fibrosis lung transplant recipients 10 years of age or younger: Predisposing factors for end-stage disease.
    Pediatr Pulmonol. 2022;57:1513-1519.
    PubMed     Abstract available


  64. SUNMAN B, Emiralioglu N, Hazirolan G, Sener B, et al
    Effectiveness of different eradication treatment protocols for new-onset Pseudomonas aeruginosa in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:1456-1465.
    PubMed     Abstract available



  65. V. YOUNG INVESTIGATOR'S ORAL COMMUNICATIONS.
    Pediatr Pulmonol. 2022;57 Suppl 2:S89-S93.
    PubMed    


    May 2022
  66. COUSINS M, Hart K, Williams EM, Kotecha S, et al
    Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated obstructive lung disease.
    Pediatr Pulmonol. 2022 May 30. doi: 10.1002/ppul.26019.
    PubMed     Abstract available


  67. CORSINI I, Parri N, Ficial B, Ciarcia M, et al
    Lung ultrasound in Italian Neonatal Intensive Care Units: a national survey.
    Pediatr Pulmonol. 2022 May 30. doi: 10.1002/ppul.26025.
    PubMed     Abstract available


  68. EL-SHEIKH M, Elmahdy H, Nassar M, Fouda M, et al
    Role of Soluble Triggering Receptors Expressed on Myeloid Cells -1 and 25-hydroxy Vitamin D as Early Diagnostic Markers of Neonatal Ventilator-Associated Pneumonia: A Prospective Cohort Study.
    Pediatr Pulmonol. 2022 May 27. doi: 10.1002/ppul.26016.
    PubMed     Abstract available


  69. VERD S, Morey R, Ginovart G, Moliner E, et al
    Due emphasis on the role of human milk feeding to prevent neonatal respiratory morbidity.
    Pediatr Pulmonol. 2022 May 26. doi: 10.1002/ppul.26017.
    PubMed     Abstract available


  70. KUGELMAN A
    *Neonatal Pulmonology: "Year in Review" for the Pediatric Pulmonologist.
    Pediatr Pulmonol. 2022 May 20. doi: 10.1002/ppul.25960.
    PubMed     Abstract available


  71. SOONG WJ, Tsao PC, Yang CF, Sung YH, et al
    Early detection of laryngeal cleft in infants by novel technique of flexible endoscopy with sustained pharyngeal inflation.
    Pediatr Pulmonol. 2022 May 20. doi: 10.1002/ppul.25988.
    PubMed     Abstract available


  72. MIKHAEL M, Cleary JP, Zaniletti I, Truog WE, et al
    Chronic Lung Disease in Full-Term Infants: Characteristics and Neonatal Intensive Care Outcomes in Infants Referred to Children's Hospitals.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25983.
    PubMed     Abstract available


  73. LUCIA L, Correani A, Pasqualini M, Antognoli L, et al
    Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25979.
    PubMed     Abstract available


  74. MONTERO-GATO J, Rodeno-Fernandez L, Serna-Guerediaga I, Aguirre-Unceta-Barrenechea A, et al
    Response to the letter entitled: "Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs; Methodological issues".
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25976.
    PubMed     Abstract available


  75. SABOUR S
    Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs; Methodological issues.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25977.
    PubMed     Abstract available


  76. WELBEL RZ, Rand CM, Zhou A, Fadl-Alla A, et al
    Neurocognitive Monitoring in Congenital Central Hypoventilation Syndrome with the NIH Toolbox.
    Pediatr Pulmonol. 2022 May 16. doi: 10.1002/ppul.25973.
    PubMed     Abstract available


  77. LIM AM, Tan PL, Visruthan NK, Fong N, et al
    HIDEA Syndrome: A rare cause of congenital hypoventilation in a premature infant.
    Pediatr Pulmonol. 2022 May 11. doi: 10.1002/ppul.25966.
    PubMed     Abstract available


  78. GOUSSARD P, Merven M, Parker N, Gie A, et al
    Foreign body aspiration in two young infants: The devil in the carpet.
    Pediatr Pulmonol. 2022 May 11. doi: 10.1002/ppul.25965.
    PubMed     Abstract available


  79. ARIFF S, Ali KQ, Tessaro MO, Ansari U, et al
    Diagnostic Accuracy of Point-of-Care Ultrasound Compared to Standard-of-Care Methods for Endotracheal Tube Placement in Neonates.
    Pediatr Pulmonol. 2022 May 2. doi: 10.1002/ppul.25955.
    PubMed     Abstract available


  80. FRAUCHIGER BS, Oestreich MA, Wyler F, Monney N, et al
    Do clinimetric properties of LCI change after correction of signal processing?
    Pediatr Pulmonol. 2022;57:1180-1187.
    PubMed     Abstract available


  81. KENIS-COSKUN O, Aksoy AN, Kumas EN, Yilmaz A, et al
    The effect of telerehabilitation on quality of life, anxiety, and depression in children with cystic fibrosis and caregivers: A single-blind randomized trial.
    Pediatr Pulmonol. 2022;57:1262-1271.
    PubMed     Abstract available


  82. KRAMER-GOLINKOFF E, Camacho A, Kramer L, Taylor-Cousar JL, et al
    A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators.
    Pediatr Pulmonol. 2022;57:1253-1261.
    PubMed     Abstract available


  83. LIM JT, Ly NP, Willen SM, Iwanaga K, et al
    Food insecurity and mental health during the COVID-19 pandemic in cystic fibrosis households.
    Pediatr Pulmonol. 2022;57:1238-1244.
    PubMed     Abstract available


  84. ASFUROGLU P, Sismanlar Eyuboglu T, Aslan AT, Gursoy TR, et al
    The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care.
    Pediatr Pulmonol. 2022;57:1245-1252.
    PubMed     Abstract available


    April 2022
  85. GHOSH RN, Guglani L, Westbrook AL, Mao CY, et al
    Impaired Ventilation during Six-Minute Walk Test in Congenital Central Hypoventilation Syndrome.
    Pediatr Pulmonol. 2022 Apr 22. doi: 10.1002/ppul.25940.
    PubMed     Abstract available


  86. IZQUIERDO ME, Marion CR, Moore WC, Raraigh K, et al
    DNA Sequencing Analysis of Cystic Fibrosis Transmembrane Regulator Gene Identifies Cystic Fibrosis-Associated Variants in the Severe Asthma Research Program.
    Pediatr Pulmonol. 2022 Apr 21. doi: 10.1002/ppul.25939.
    PubMed     Abstract available


  87. ZAITSU M, Matsuo M
    Transient low IgG4 levels cause recurrent wheezing requiring multiple hospitalizations in infancy.
    Pediatr Pulmonol. 2022 Apr 18. doi: 10.1002/ppul.25927.
    PubMed     Abstract available


  88. FELDMAN K, Nitkin CR, Cuna A, Oschman A, et al
    Corticosteroid Response Predicts Bronchopulmonary Dysplasia Status at 36 Weeks in Preterm Infants Treated with Dexamethasone: A Pilot Study.
    Pediatr Pulmonol. 2022 Apr 17. doi: 10.1002/ppul.25928.
    PubMed     Abstract available


  89. KOUCKY V, Komarek A, Pohunek P
    Repeatability of lung clearance index in infants with cystic fibrosis and recurrent wheeze.
    Pediatr Pulmonol. 2022 Apr 13. doi: 10.1002/ppul.25921.
    PubMed     Abstract available


  90. MATERA L, Nenna R, Frassanito A, Petrarca L, et al
    Low lymphocyte count: a clinical severity marker in infants with bronchiolitis.
    Pediatr Pulmonol. 2022 Apr 11. doi: 10.1002/ppul.25919.
    PubMed     Abstract available


  91. BISQUERA A, MBChB CH, Lunt A, Zivanovic S, et al
    Longitudinal changes in lung function in very prematurely born young people receiving high frequency oscillation or conventional ventilation from birth.
    Pediatr Pulmonol. 2022 Apr 6. doi: 10.1002/ppul.25918.
    PubMed     Abstract available


  92. CALISKAN AB, Horani A, Manion M, Brody SL, et al
    Variations in infection control practices suggest a need for guidelines in primary ciliary dyskinesia patient care.
    Pediatr Pulmonol. 2022;57:1072-1075.
    PubMed     Abstract available


  93. MANZAR S
    Successful Extubation in Preterm Infants.
    Pediatr Pulmonol. 2022 Apr 1. doi: 10.1002/ppul.25908.
    PubMed     Abstract available


  94. KENNEDY C, Greenberg I, Perez GF, Chaney H, et al
    Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:965-975.
    PubMed     Abstract available


  95. MANIKA K, Hatziagorou E, Kotoulas SC, Kyrvasili SS, et al
    Adherence to inhaled therapies over 4 years in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:956-964.
    PubMed     Abstract available


  96. LAI HJ, Chin LH, Murali S, Bach T, et al
    Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:935-944.
    PubMed     Abstract available


  97. IMBURGIA TA, Engdahl SR, Pettit RS
    Evaluation of the safety of cefepime prolonged infusions in pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:919-925.
    PubMed     Abstract available


  98. SHAKKOTTAI A, Irani S, Nasr SZ, O'Brien LM, et al
    Risk factors for obstructive sleep apnea in cystic fibrosis.
    Pediatr Pulmonol. 2022;57:926-934.
    PubMed     Abstract available


  99. SAKON C, Alicea LA, Patacca H, Brown CD, et al
    Opportunity for pharmacogenomic testing in patients with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:903-907.
    PubMed     Abstract available


  100. ZAMPOLI M, Kassanjee R, Verstraete J, Westwood A, et al
    Trends in cystic fibrosis survival over 40 years in South Africa: An observational cohort study.
    Pediatr Pulmonol. 2022;57:908-918.
    PubMed     Abstract available


    March 2022
  101. GUPTA VS, Wilson C, Popp EC, Zhaorigetu S, et al
    Neonatal rodent ventilation and clinical correlation in congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2022 Mar 30. doi: 10.1002/ppul.25911.
    PubMed     Abstract available


  102. SCHOBER M, Bohnhorst B, Annon-Eberharter N, Wald M, et al
    Dead space washout by intentional leakage flow during conventional ventilation of premature infants - an experimental study.
    Pediatr Pulmonol. 2022 Mar 30. doi: 10.1002/ppul.25906.
    PubMed     Abstract available


  103. RALLIS D, Baltogianni M, Dermitzaki N, Balomenou F, et al
    Clara Cell Protein Expression Amongst Infants with Respiratory Distress Syndrome.
    Pediatr Pulmonol. 2022 Mar 18. doi: 10.1002/ppul.25897.
    PubMed     Abstract available


  104. ARAKI R, Tomotaki S, Akita M, Motokura K, et al
    Effect of doxapram on the electrical activity of the diaphragm waveform pattern of preterm infants.
    Pediatr Pulmonol. 2022 Mar 11. doi: 10.1002/ppul.25889.
    PubMed     Abstract available


  105. PIATEK K, Lehtonen L, Parikka V, Setanen S, et al
    Implementation of neurally adjusted ventilatory assist and high flow nasal cannula in very preterm infants in a tertiary level NICU.
    Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25879.
    PubMed     Abstract available


  106. GOUSSARD P, Schubert P, Parker N, Myburgh C, et al
    GOUSSARD et al."To the Editor"Fatal SARS-CoV-2 Omicron variant in a young infant: Autopsy findings.
    Pediatr Pulmonol. 2022 Mar 3. doi: 10.1002/ppul.25881.
    PubMed    


  107. SUNMAN B, Emiralioglu N, Hazirolan G, Ademhan Tural D, et al
    Impact of Achromobacter spp. isolation on clinical outcomes in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:658-666.
    PubMed     Abstract available


  108. WRIGHT BA, Ketchen NK, Rasmussen LN, Bartels AR, et al
    Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients.
    Pediatr Pulmonol. 2022;57:655-657.
    PubMed     Abstract available


  109. SATHE M, Paul GR, Faro A
    A step back in time: The basics of CF care still matter!
    Pediatr Pulmonol. 2022;57:597-599.
    PubMed    


  110. KAUR H, Pandey S, Jat KR, Lodha R, et al
    Predictors of mortality in children with cystic fibrosis in India.
    Pediatr Pulmonol. 2022;57:648-654.
    PubMed     Abstract available


    February 2022
  111. CORSINI I, Ciarcia M, Ficial B, Capasso L, et al
    LUNG ULTRASOUND SCORES IN NEONATAL CLINICAL PRACTICE: A NARRATIVE REVIEW OF THE LITERATURE.
    Pediatr Pulmonol. 2022 Feb 28. doi: 10.1002/ppul.25875.
    PubMed     Abstract available


  112. KORPPI M
    Eosinophil activity in infancy predicts the outcome of infant bronchiolitis.
    Pediatr Pulmonol. 2022 Feb 27. doi: 10.1002/ppul.25871.
    PubMed     Abstract available


  113. SCHNAPPER M, Dalal I, Mandelberg A, Sternfeld AR, et al
    Bronchoscopy in the management of children from developing countries undergoing congenital heart surgery.
    Pediatr Pulmonol. 2022 Feb 24. doi: 10.1002/ppul.25869.
    PubMed     Abstract available


  114. BUCK CO, Taylor SN
    Commentary on "Compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants - an observational study".
    Pediatr Pulmonol. 2022 Feb 21. doi: 10.1002/ppul.25867.
    PubMed     Abstract available


  115. BEHNKE J, Estreich V, Oehmke F, Zimmer KP, et al
    Compatibility of rapid enteral feeding advances and non-invasive ventilation in preterm infants - an observational study.
    Pediatr Pulmonol. 2022 Feb 21. doi: 10.1002/ppul.25868.
    PubMed     Abstract available


  116. XU KK, Wegner DJ, Geurts LC, Heins HB, et al
    Biologic Characterization of ABCA3 Variants in Lung Tissue from Infants and Children with ABCA3 Deficiency.
    Pediatr Pulmonol. 2022 Feb 15. doi: 10.1002/ppul.25862.
    PubMed     Abstract available


  117. RAGAN H, Autry E, Bomersback T, Hewlett J, et al
    The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series.
    Pediatr Pulmonol. 2022;57:411-417.
    PubMed     Abstract available


  118. ANTOS NJ, Savant AP
    Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation.
    Pediatr Pulmonol. 2022;57:347-360.
    PubMed     Abstract available


  119. MCBENNETT KA, Davis PB, Konstan MW
    Increasing life expectancy in cystic fibrosis: Advances and challenges.
    Pediatr Pulmonol. 2022;57 Suppl 1:S5-S12.
    PubMed     Abstract available


  120. JOBANPUTRA A, Jagpal S, Marulanda P, Ramagopal M, et al
    An overview of noninvasive ventilation in cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S101-S112.
    PubMed     Abstract available


  121. GABEL ME, Fox CK, Grimes RA, Lowman JD, et al
    Overweight and cystic fibrosis: An unexpected challenge.
    Pediatr Pulmonol. 2022;57 Suppl 1:S40-S49.
    PubMed     Abstract available


  122. SALA MA, Vitale KM, Prickett M
    Looking toward the future: Approaching care of the aging CF patient.
    Pediatr Pulmonol. 2022;57 Suppl 1:S113-S117.
    PubMed     Abstract available


  123. ROWBOTHAM NJ, Daniels TE
    Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life.
    Pediatr Pulmonol. 2022;57 Suppl 1:S50-S59.
    PubMed     Abstract available


  124. WRIGHT M, Wright T
    Health disparity in CF: Perspectives from a lived experience.
    Pediatr Pulmonol. 2022;57 Suppl 1:S13-S16.
    PubMed     Abstract available


  125. WEST NE, Kazmerski TM, Taylor-Cousar JL, Tangpricha V, et al
    Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S89-S100.
    PubMed     Abstract available


  126. LAHIRI T, Sullivan JS
    Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy.
    Pediatr Pulmonol. 2022;57 Suppl 1:S60-S74.
    PubMed     Abstract available


  127. KAZMERSKI TM, West NE, Jain R, Uluer A, et al
    Family-building and parenting considerations for people with cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S75-S88.
    PubMed     Abstract available


  128. GRANT JJ, McDade EJ, Zobell JT, Young DC, et al
    The indispensable role of pharmacy services and medication therapy management in cystic fibrosis.
    Pediatr Pulmonol. 2022;57 Suppl 1:S17-S39.
    PubMed     Abstract available


    January 2022
  129. SOLA-MARTINEZ RA, Sanchez-Solis M, Lozano-Terol G, Gallego-Jara J, et al
    Relationship between lung function and exhaled volatile organic compounds in healthy infants.
    Pediatr Pulmonol. 2022 Jan 29. doi: 10.1002/ppul.25849.
    PubMed     Abstract available


  130. BEQIRAJ-ZEQIRAJ Q, Thaci Q, Sahiti F, Kovac Z, et al
    Rho-kinase inhibitors protect against neonatal hyperoxia-induced airway hyperreactivity in a rat pup model: role of prostaglandin F2alpha.
    Pediatr Pulmonol. 2022 Jan 28. doi: 10.1002/ppul.25848.
    PubMed     Abstract available


  131. GEORGE A, Ortenberg R, Pinto S
    A case of Recurrent Pneumothoraces in a Newborn.
    Pediatr Pulmonol. 2022 Jan 25. doi: 10.1002/ppul.25844.
    PubMed     Abstract available


  132. IWAI M, Yoshimatsu H, Naramura T, Imamura H, et al
    Procalcitonin is associated with postnatal respiratory condition severity in preterm neonate: Conclusion: The serum PCT levels in preterm neonates were associated with postnatal respiratory condition severity.
    Pediatr Pulmonol. 2022 Jan 22. doi: 10.1002/ppul.25846.
    PubMed     Abstract available


  133. DE QUEIROZ ANDRADE E, Bayfield KJ, Blaxland A, Wong A, et al
    Exposure to 4% SF6 during multiple breath washout affects subsequent infant tidal breathing analysis.
    Pediatr Pulmonol. 2022 Jan 20. doi: 10.1002/ppul.25820.
    PubMed    


  134. ELGENDY MM, Aly H, Adisa A, Mohamed MA, et al
    Disparities in tracheostomies and gastrostomy tubes in infants at the edge of viability.
    Pediatr Pulmonol. 2022 Jan 20. doi: 10.1002/ppul.25841.
    PubMed     Abstract available


  135. RUSCONI F, Lombardi E, Spada E, Brescianini S, et al
    Lung function at school age in infants with lower respiratory tract infections with and without wheezing: a birth cohort study.
    Pediatr Pulmonol. 2022 Jan 19. doi: 10.1002/ppul.25835.
    PubMed     Abstract available


  136. LI J, Zhang J, Hao Q, Chen H, et al
    Erythropoietin for preventing bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
    Pediatr Pulmonol. 2022 Jan 18. doi: 10.1002/ppul.25837.
    PubMed     Abstract available


  137. BEYDON N, Lucas JS
    Letter to the Editor on "Feasibility of nasal NO screening in healthy newborns".
    Pediatr Pulmonol. 2022 Jan 17. doi: 10.1002/ppul.25784.
    PubMed    


  138. MOHSEN N, Nasef N, Elkhouli M, Ghanem M, et al
    Predictors of Successful Trial off Continuous Positive Airway Pressure and High Flow Nasal Cannula in Preterm Infants < 30 weeks| gestation: A Retrospective Study.
    Pediatr Pulmonol. 2022 Jan 15. doi: 10.1002/ppul.25827.
    PubMed     Abstract available


  139. SANDVIK RM, Gustafsson PM, Lindblad A, Buchvald F, et al
    Contemporary N2 and SF6 multiple breath washout in infants and toddlers with cystic fibrosis.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25830.
    PubMed     Abstract available


  140. GATO JM, Fernandez LR, Guerediaga IS, Unceta-Barrenechea AA, et al
    Ultrasound of Pneumothorax in Neonates: Diagnostic Value of the Anterior Transverse Plane and of Mirrored Ribs.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25829.
    PubMed     Abstract available


  141. ADAIKALAM SA, Higano NS, Hysinger EB, Bates AJ, et al
    Tracheostomy prediction model in neonatal bronchopulmonary dysplasia via lung and airway MRI.
    Pediatr Pulmonol. 2022 Jan 13. doi: 10.1002/ppul.25826.
    PubMed     Abstract available


  142. WONG CK, Harris L, Hicks M, Majaesic C, et al
    Tracheostomies in Term and Preterm Infants: A Single Center Canadian Retrospective Cohort.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25823.
    PubMed     Abstract available


  143. DANI C, Ciarcia M, Miselli F, Luzzati M, et al
    MEASUREMENT OF LUNG OXYGENATION BY NEAR INFRARED SPECTROSCOPY IN PRETERM INFANTS WITH RESPIRATORY DISTRESS SYNDROME: A PROOF OF CONCEPT STUDY.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25824.
    PubMed     Abstract available


  144. ROSENFELD N, Mandelberg A, Dalal I, Tasher D, et al
    The Impact of the COVID-19 Pandemic on respiratory morbidity during infancy: A birth-cohort study.
    Pediatr Pulmonol. 2022 Jan 11. doi: 10.1002/ppul.25822.
    PubMed     Abstract available


  145. O'CONNOR K, Hurst C, Llewellyn S, Davies M, et al
    Factors associated with successful extubation following the first course of systemic dexamethasone in ventilator dependent preterm infants with or at risk of developing bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2022 Jan 7. doi: 10.1002/ppul.25821.
    PubMed     Abstract available


  146. GENTLE SJ, Sant'Anna G, Carlo WA
    Using Dexamethasone Wisely in Invasively Ventilated Preterm Infants.
    Pediatr Pulmonol. 2022 Jan 7. doi: 10.1002/ppul.25819.
    PubMed     Abstract available


  147. GE H, Qiao Y, Ge J, Li J, et al
    Effects of early Vitamin D supplementation on the prevention of bronchopulmonary dysplasia in preterm infants.
    Pediatr Pulmonol. 2022 Jan 6. doi: 10.1002/ppul.25813.
    PubMed     Abstract available


  148. KIELT MJ, Murphy A, Smathers J, Bates M, et al
    In-hospital respiratory viral infections for patients with established BPD in the SARS-CoV-2 era.
    Pediatr Pulmonol. 2022;57:200-208.
    PubMed     Abstract available


  149. FETTES E, Riley M, Brotherston S, Doughty C, et al
    "You're on mute!" Does pediatric CF home spirometry require physiologist supervision?
    Pediatr Pulmonol. 2022;57:278-284.
    PubMed     Abstract available


  150. ADEMHAN TURAL D, Yalcin E, Emiralioglu N, Ozsezen B, et al
    Comparison of inhaled mannitol/dornase alfa combination and daily dornase alfa alone in children with cystic fibrosis.
    Pediatr Pulmonol. 2022;57:142-151.
    PubMed     Abstract available


  151. POORE TS, Meier M, Towler E, Martiniano SL, et al
    Clinical characteristics of people with cystic fibrosis and frequent fungal infection.
    Pediatr Pulmonol. 2022;57:152-161.
    PubMed     Abstract available


  152. MARIANI A, Gambazza S, Carta F, Ambrogi F, et al
    Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: An Italian single-center cross-sectional analysis.
    Pediatr Pulmonol. 2022;57:132-141.
    PubMed     Abstract available


  153. SEBLANI MD, McColley SA, Gong S, Bass LM, et al
    A rare case of pancytopenia in a child with cystic fibrosis: Can copper cure it all?
    Pediatr Pulmonol. 2022;57:317-319.
    PubMed    


  154. DEVI U, Roberts KD, Pandita A
    A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: Methods, limitations, and outcomes.
    Pediatr Pulmonol. 2022;57:9-19.
    PubMed     Abstract available


    December 2021
  155. RIGOTTI C, Zannin E, Abdelfattah AS, Ventura ML, et al
    Assessment of bronchodilator response by forced oscillation technique in a preterm infant with evolving bronchopulmonary dysplasia: a case report.
    Pediatr Pulmonol. 2021 Dec 30. doi: 10.1002/ppul.25812.
    PubMed     Abstract available


  156. SZABO H, Baraldi E, Colin AA
    Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part II. Inhaled corticosteroids alone or in combination with surfactants.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25808.
    PubMed     Abstract available


  157. SZABO H, Baraldi E, Colin AA
    Corticosteroids in the prevention and treatment of infants with bronchopulmonary dysplasia: Part I. Systemic corticosteroids.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25805.
    PubMed     Abstract available


  158. LANGFELDER-SCHWIND E, Raraigh KS, Parad RB
    Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: consensus guidelines.
    Pediatr Pulmonol. 2021 Dec 29. doi: 10.1002/ppul.25806.
    PubMed     Abstract available


  159. GUPTA N, Chattopadhyay A, Nyayadhish RK, Saikia D, et al
    Necrotising MRSA pneumonia with mycotic pulmonary artery pseudo - aneurysm in an infant.
    Pediatr Pulmonol. 2021 Dec 22. doi: 10.1002/ppul.25800.
    PubMed    


  160. PELES G, Paz-Levy D, Wainstock T, Goldbart A, et al
    Pediatric respiratory hospitalizations in small for gestational age neonates born at term.
    Pediatr Pulmonol. 2021 Dec 20. doi: 10.1002/ppul.25797.
    PubMed     Abstract available


  161. BALAZS G, Balajthy A, Riszter M, Kovacs T, et al
    Incidence, predictors of success and outcome of LISA in very preterm infants.
    Pediatr Pulmonol. 2021 Dec 20. doi: 10.1002/ppul.25798.
    PubMed     Abstract available


  162. FRASSANITO A, Nenna R, Arima S, Petrarca L, et al
    Modifiable environmental factors predispose term infants to bronchiolitis but bronchiolitis itself predisposes to respiratory sequelae.
    Pediatr Pulmonol. 2021 Dec 17. doi: 10.1002/ppul.25794.
    PubMed     Abstract available


  163. RAMIREZ-SUAREZ KI, Barrera CA, Otero HJ, Biko DM, et al
    Pilot study for comparative assessment of dual-energy computed tomography and single-photon emission computed tomography V/Q scanning for lung perfusion evaluation in infants.
    Pediatr Pulmonol. 2021 Dec 16. doi: 10.1002/ppul.25788.
    PubMed     Abstract available


  164. XU W, Gao Y, Li W, Chen Z, et al
    A National descriptive epidemiologic analysis on congenital pulmonary airway malformation in China, 2010-2019.
    Pediatr Pulmonol. 2021 Dec 9. doi: 10.1002/ppul.25785.
    PubMed     Abstract available


  165. VIRGIN FW, Thurm C, Sanders DB, Freeman AJ, et al
    Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:4029-4038.
    PubMed     Abstract available


  166. MASSIE J
    Miracles in my time: Reflections of a pediatric respiratory physician.
    Pediatr Pulmonol. 2021;56:3586-3591.
    PubMed     Abstract available


  167. ALIBAKHSHI R, Mohammadi A, Khamooshian S, Kazeminia M, et al
    CFTR gene mutation spectrum among 735 Iranian patients with cystic fibrosis: A comprehensive systematic review.
    Pediatr Pulmonol. 2021;56:3644-3656.
    PubMed     Abstract available


  168. ANDERSON A, McCoy L, Pettit RS, Wright BA, et al
    Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis.
    Pediatr Pulmonol. 2021;56:4053-4054.
    PubMed    


  169. WILSON LM, Ellis MJ, Lane RL, Wilson JW, et al
    Development of the A-STEP: A new incremental maximal exercise capacity step test in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3777-3784.
    PubMed     Abstract available


  170. BOKOV P, Gerardin M, Le Clainche L, Houdouin V, et al
    Impulse oscillometry indices to detect an abnormal lung clearance index in childhood cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3752-3757.
    PubMed     Abstract available


  171. MURSALOGLU HH, Akin C, Yilmaz Yegit C, Ergenekon AP, et al
    Comparison of intravenous and non-intravenous antibiotic regimens in eradication of P. aeruginosa and MRSA in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3745-3751.
    PubMed     Abstract available


  172. MCCASHNEY A, Robinson P
    Structural lung disease following allergic bronchopulmonary aspergillosis complicating pediatric cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3737-3744.
    PubMed     Abstract available


  173. GOETZ DM, Savant AP
    Review of CFTR modulators 2020.
    Pediatr Pulmonol. 2021;56:3595-3606.
    PubMed     Abstract available


  174. OCHS MA, Dillman NO, Caverly LJ, Chaffee VD, et al
    Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3634-3643.
    PubMed     Abstract available


    November 2021
  175. NAYIR BUYUKSAHIN H, Emiralioglu N, Ozsezen B, Ademhan Tural D, et al
    Cystic Fibrosis Newborn Screening: Five-year Experience from a Tertiary Care Center.
    Pediatr Pulmonol. 2021 Nov 29. doi: 10.1002/ppul.25778.
    PubMed     Abstract available


  176. PELUSO AM, Othman HF, Karnati S, Sammour I, et al
    Epidemiologic evaluation of inhaled nitric oxide use among neonates with gestational age less than 35 weeks.
    Pediatr Pulmonol. 2021 Nov 29. doi: 10.1002/ppul.25775.
    PubMed     Abstract available


  177. WHITE H, Sobelman C, Kremer T, Lee A, et al
    Does Recorded Oximetry Utilizing a Consensus Based Algorithm Compare to Polysomnography in Discontinuing Home Oxygen Therapy in Premature Infants.
    Pediatr Pulmonol. 2021 Nov 23. doi: 10.1002/ppul.25770.
    PubMed     Abstract available


  178. BUENDIA JA, Ramirez C, Benjumea-Bedoya D
    Bronchopulmonary dysplasia: incidence and severity in premature infants born at high altitude.
    Pediatr Pulmonol. 2021 Nov 18. doi: 10.1002/ppul.25763.
    PubMed     Abstract available


  179. NOBILE S, Marchionni P, Meneghin F, Salvatore S, et al
    Esophageal impedance baseline in infants with bronchopulmonary dysplasia: a pilot study.
    Pediatr Pulmonol. 2021 Nov 15. doi: 10.1002/ppul.25758.
    PubMed     Abstract available


  180. TANG W, Chen S, Shi D, Ai T, et al
    Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for Bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Pediatr Pulmonol. 2021 Nov 15. doi: 10.1002/ppul.25759.
    PubMed     Abstract available


  181. VOYNOW JA, Feng R, Ren CL, Dylag AM, et al
    Pulmonary function tests in extremely low gestational age infants at one year of age.
    Pediatr Pulmonol. 2021 Nov 14. doi: 10.1002/ppul.25757.
    PubMed     Abstract available


  182. CUEVAS GUAMAN M, Dahm PH, Welty SE
    The challenge of accurately describing the epidemiology of bronchopulmonary dysplasia (BPD) based on the various current definitions of BPD.
    Pediatr Pulmonol. 2021;56:3527-3532.
    PubMed     Abstract available


  183. HYSINGER EB
    Central airway issues in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3518-3526.
    PubMed     Abstract available


  184. YALLAPRAGADA SG, Savani RC, Goss KN
    Cardiovascular impact and sequelae of bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3453-3463.
    PubMed     Abstract available


  185. COLLACO JM, McGrath-Morrow SA
    Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.
    Pediatr Pulmonol. 2021;56:3464-3471.
    PubMed     Abstract available


  186. BAKER CD
    Chronic respiratory failure in bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:3490-3498.
    PubMed     Abstract available


  187. ALLEN J, Panitch H
    Bronchopulmonary dysplasia-A historical perspective.
    Pediatr Pulmonol. 2021;56:3478-3489.
    PubMed     Abstract available


    October 2021
  188. BAKHLE A, Sreekumar K, Baracho B, Sardessai S, et al
    Cavitary lung lesions in a neonate: Potential manifestation of COVID-19 related multisystem inflammatory syndrome.
    Pediatr Pulmonol. 2021 Oct 29. doi: 10.1002/ppul.25732.
    PubMed     Abstract available


  189. LI J, Xu H
    Comparisons of two definitions of Bronchopulmonary Dysplasia for the premature infants.
    Pediatr Pulmonol. 2021 Oct 23. doi: 10.1002/ppul.25739.
    PubMed     Abstract available


  190. XU S, Yang C, Gan Y, Jiang G, et al
    A 4-day-old newborn with an isolated sternal cleft: A rare case and literature review.
    Pediatr Pulmonol. 2021 Oct 12. doi: 10.1002/ppul.25677.
    PubMed     Abstract available


  191. LEWIS L, Sinha I, Losty PD
    Respiratory Syncytial Virus Bronchiolitis in Congenital Diaphragmatic Hernia: A systematic review of prevalence rates and Palivizumab prophylaxis.
    Pediatr Pulmonol. 2021 Oct 6. doi: 10.1002/ppul.25717.
    PubMed     Abstract available


  192. DELL'ORTO V, Nobile S, Correani A, Marchionni P, et al
    Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.
    Pediatr Pulmonol. 2021 Oct 5. doi: 10.1002/ppul.25678.
    PubMed     Abstract available


  193. WANG Y, Hong X, Yao TC, Tsai HJ, et al
    Interaction of maternal asthma history and plasma folate levels on child asthma risk in the Boston Birth Cohort.
    Pediatr Pulmonol. 2021 Oct 4. doi: 10.1002/ppul.25680.
    PubMed     Abstract available


  194. ANDERSON E, Gregoski MJ, Gehle D, Head WT, et al
    Severity of respiratory disease is correlated with time of first oral feeding and need for a gastrostomy tube at discharge in premature infants born at <30 weeks of gestation.
    Pediatr Pulmonol. 2021 Oct 1. doi: 10.1002/ppul.25713.
    PubMed     Abstract available


  195. DEVI U, Pandita A
    Surfactant delivery via thin catheters: Methods, limitations, and outcomes.
    Pediatr Pulmonol. 2021;56:3126-3141.
    PubMed     Abstract available


  196. SALVATORE D, Carnovale V, Majo F, Padoan R, et al
    Disease characterization of people with cystic fibrosis and a minimal function mutation: Data from the Italian registry.
    Pediatr Pulmonol. 2021;56:3232-3241.
    PubMed     Abstract available


  197. SHARMA PB, Sathe M, Savant AP
    Year in Review 2020: Multisystemic impact of cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3110-3119.
    PubMed     Abstract available


  198. SATHE M, Sharma PB, Savant AP
    Year in review 2020: Nutrition and gastrointestinal disease in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3120-3125.
    PubMed     Abstract available


  199. DACCO V, Rosazza C, Malfitano A, Sciarrabba CS, et al
    Cytokine storm syndrome in a young patient with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:3435-3437.
    PubMed     Abstract available


  200. ARARAT E, Sonawalla A, Berlinski A, Tas E, et al
    Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence.
    Pediatr Pulmonol. 2021;56:3217-3222.
    PubMed     Abstract available


  201. LANDMESSER KB, Autry EB, Gardner BM, Bosko KA, et al
    Comparison of the predictive value of area under the curve versus maximum serum concentration of intravenous tobramycin in cystic fibrosis patients treated for an acute pulmonary exacerbation.
    Pediatr Pulmonol. 2021;56:3209-3216.
    PubMed     Abstract available


  202. CAUDRI D, Turkovic L, Klerk NH, Rosenow T, et al
    A screening tool to identify risk for bronchiectasis progression in children with cystic fibrosis.
    Pediatr Pulmonol. 2021 Oct 1. doi: 10.1002/ppul.25712.
    PubMed     Abstract available


    September 2021
  203. OZDEMIR R, Gokce IK, Tekin S, Taslidere AC, et al
    The Protective Effects of Apocynin in Hyperoxic Lung Injury in Neonatal Rats.
    Pediatr Pulmonol. 2021 Sep 28. doi: 10.1002/ppul.25707.
    PubMed     Abstract available


  204. BUECHEL F, Usemann J, Aline A, Salfeld P, et al
    Feasibility of nasal NO screening in healthy newborns.
    Pediatr Pulmonol. 2021 Sep 27. doi: 10.1002/ppul.25702.
    PubMed     Abstract available


  205. HATZIAGOROU E, Toulia I, Avramidou V, Kampouras A, et al
    Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting.
    Pediatr Pulmonol. 2021;56:3065-3067.
    PubMed     Abstract available


  206. NAYIR BUYUKSAHIN H, Emiralioglu N, Ademhan Tural D, Ozsezen B, et al
    Impact of COVID-19 on pediatric pulmonology healthcare practice.
    Pediatr Pulmonol. 2021;56:2811-2817.
    PubMed     Abstract available


  207. COLLACO N, Legg J, Day M, Culliford D, et al
    COVID-19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents.
    Pediatr Pulmonol. 2021;56:2845-2853.
    PubMed     Abstract available


  208. MUIRHEAD CA, Palmrose W, Condren M, Rotolo SM, et al
    A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2879-2887.
    PubMed     Abstract available


  209. PORTERFIELD HS, Maakestad LJ, LaMarche MM, Thurman AL, et al
    MRSA strains with distinct accessory genes predominate at different ages in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2868-2878.
    PubMed     Abstract available


  210. BELCHER R, Zobell JT
    Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol.
    Pediatr Pulmonol. 2021;56:3059-3061.
    PubMed     Abstract available


  211. BURRUS TE, Vogt H, Pettit RS
    Impact of a pharmacy technician and pharmacist on time to inhaled tobramycin therapy in a pediatric cystic fibrosis clinic.
    Pediatr Pulmonol. 2021;56:2861-2867.
    PubMed     Abstract available


  212. THORAT T, McGarry LJ, Bonafede MM, Limone BL, et al
    Healthcare resource utilization and costs among children with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2021;56:2833-2844.
    PubMed     Abstract available


    August 2021
  213. MCGLYNN JR, Aoyama BC, Collaco JM, McGrath-Morrow SA, et al
    Family history of asthma influences outpatient respiratory outcomes in children with BPD.
    Pediatr Pulmonol. 2021 Aug 8. doi: 10.1002/ppul.25603.
    PubMed     Abstract available


  214. OTA C, Saito R, Tominaga J, Iwasawa S, et al
    Bilateral lung transplantation in a 9-year-old girl with bronchopulmonary dysplasia with pulmonary hypertension.
    Pediatr Pulmonol. 2021 Aug 5. doi: 10.1002/ppul.25597.
    PubMed     Abstract available


  215. YANG K, He S, Dong W
    Gut microbiota and bronchopulmonary dysplasia.
    Pediatr Pulmonol. 2021;56:2460-2470.
    PubMed     Abstract available


  216. GOMES A, Patusco R, Chung M, Dreker MR, et al
    The associations between pediatric weight status and cystic fibrosis-related diabetes status and health-related quality of life among children and young adults with cystic fibrosis: A systematic review.
    Pediatr Pulmonol. 2021;56:2413-2425.
    PubMed     Abstract available


    July 2021
  217. MALLOY KW, Austin ED
    Pulmonary Hypertension in the child with Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2021 Jul 29. doi: 10.1002/ppul.25602.
    PubMed     Abstract available


  218. EPPS QJ, Epps KL, Young DC, Zobell JT, et al
    State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary.
    Pediatr Pulmonol. 2021;56:1825-1837.
    PubMed     Abstract available


  219. GIFFORD AH, Sanville JL, Sathe M, Heltshe SL, et al
    Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2048-2056.
    PubMed     Abstract available


  220. POLLAK M, Shaw M, Wilson D, Solomon M, et al
    Bronchodilator responsiveness in cystic fibrosis children treated for pulmonary exacerbations.
    Pediatr Pulmonol. 2021;56:2036-2042.
    PubMed     Abstract available


  221. TREGGIARI D, Tridello G, Menin L, Borruso A, et al
    Role of sweat ion ratios in diagnosing cystic fibrosis.
    Pediatr Pulmonol. 2021;56:2023-2028.
    PubMed     Abstract available


  222. COLLINS R, Singh B, Payne DN, Bharat C, et al
    Effect of transfer from a pediatric to adult cystic fibrosis center on clinical status and hospital attendance.
    Pediatr Pulmonol. 2021;56:2029-2035.
    PubMed     Abstract available


  223. BOURGEOIS G, Magne F, Nove Josserand R, Durupt S, et al
    A formalized transition program for cystic fibrosis: A 10-year retrospective analysis of 97 patients in Lyon.
    Pediatr Pulmonol. 2021;56:2000-2006.
    PubMed     Abstract available


  224. ATLAS G, Yap M, Lim A, Vidmar S, et al
    The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: A recommendation for BMD screening.
    Pediatr Pulmonol. 2021;56:2014-2022.
    PubMed     Abstract available


  225. COHEN-CYMBERKNOH M, Ben Meir E, Gartner S, Reiter J, et al
    How abnormal is the normal? Clinical characteristics of CF patients with normal FEV1.
    Pediatr Pulmonol. 2021;56:2007-2013.
    PubMed     Abstract available


  226. HENTE E, Weiland J, Mullen L, Hawke J, et al
    Assessment of treatment burden and complexity in cystic fibrosis: A quality improvement project.
    Pediatr Pulmonol. 2021;56:1992-1999.
    PubMed     Abstract available


    June 2021
  227. BRUNO G, Donnarumma B, Inverardi A, Buonpensiero P, et al
    Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1.
    Pediatr Pulmonol. 2021;56:1806-1808.
    PubMed    


  228. BUSTAMANTE AE, Fernandez LT, Rivas LC, Mercado-Longoria R, et al
    Disparities in cystic fibrosis survival in Mexico: Impact of socioeconomic status.
    Pediatr Pulmonol. 2021;56:1566-1572.
    PubMed     Abstract available


  229. PLESKOVA J, Koucky V, Medunova K, Vlckova B, et al
    Reflex zone stimulation reduces ventilation inhomogeneity in cystic fibrosis: A randomised controlled cross-over study.
    Pediatr Pulmonol. 2021;56:1558-1565.
    PubMed     Abstract available


  230. LEITE LR, Queiroz KCV, da Silva FH, Coelho CC, et al
    Clinical use of the modified shuttle test in children with cystic fibrosis: Is one test sufficient?
    Pediatr Pulmonol. 2021;56:1550-1557.
    PubMed     Abstract available


  231. HERNANDEZ AM, Burdick B, Adeyemi-Fowode O
    Reproductive health counseling and contraceptive use in adolescents with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:1543-1549.
    PubMed     Abstract available


  232. YILMAZ YEGIT C, Ergenekon AP, Mursaloglu HH, Cenk M, et al
    The effects of nebulizer hygiene training on the practices of cystic fibrosis patients and caregivers.
    Pediatr Pulmonol. 2021;56:1527-1533.
    PubMed     Abstract available


  233. EPPS QJ, Epps KL, Zobell JT
    Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update.
    Pediatr Pulmonol. 2021;56:1784-1788.
    PubMed    


  234. MURSALOGLU HH, Yilmaz Yegit C, Ergenekon AP, Gokdemir Y, et al
    Screening of depression and anxiety in adolescents with cystic fibrosis and caregivers in Turkey by PHQ-9 and GAD-7 questionnaires.
    Pediatr Pulmonol. 2021;56:1514-1520.
    PubMed     Abstract available


  235. ASLANHAN U, Cakir E, Pur Ozyigit L, Kucuksezer UC, et al
    Pseudomonas aeruginosa colonization in cystic fibrosis: Impact on neutrophil functions and cytokine secretion capacity.
    Pediatr Pulmonol. 2021;56:1504-1513.
    PubMed     Abstract available


  236. LAFONT M, Morin C, Arrouy A, Rabeau A, et al
    Pediatrician intervention impacts parental smoking in cystic fibrosis, diabetes, and bronchiolitis.
    Pediatr Pulmonol. 2021;56:1716-1723.
    PubMed     Abstract available


  237. MCGARRY ME, McColley SA
    Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype.
    Pediatr Pulmonol. 2021;56:1496-1503.
    PubMed     Abstract available


  238. ZOBELL JT, Moss J, Heuser S, Roe L, et al
    Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care.
    Pediatr Pulmonol. 2021;56:1378-1385.
    PubMed     Abstract available


    May 2021
  239. PATEL M, McCracken C, Daley T, Stecenko A, et al
    Trajectories of oral glucose tolerance testing in cystic fibrosis.
    Pediatr Pulmonol. 2021;56:901-909.
    PubMed     Abstract available


  240. PERKINS RC, Shah M, Sawicki GS
    An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:928-938.
    PubMed     Abstract available


  241. KONSTAN MW, Pasta DJ, VanDevanter DR, Wagener JS, et al
    Epidemiologic Study of Cystic Fibrosis: 25 years of observational research.
    Pediatr Pulmonol. 2021;56:823-836.
    PubMed     Abstract available


  242. EMIRZA C, Aslan GK, Kilinc AA, Cokugras H, et al
    Effect of expiratory muscle training on peak cough flow in children and adolescents with cystic fibrosis: A randomized controlled trial.
    Pediatr Pulmonol. 2021;56:939-947.
    PubMed     Abstract available


  243. EKINCI IB, Hizal M, Emiralioglu N, Ozcelik U, et al
    Differentially expressed genes associated with disease severity in siblings with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:910-920.
    PubMed     Abstract available


  244. WILLIAMS WA 2ND, Jain M, Laguna TA, McColley SA, et al
    Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis.
    Pediatr Pulmonol. 2021;56:921-927.
    PubMed     Abstract available


  245. PEREZ-TARAZONA S, Rueda Esteban S, Garcia-Garcia ML, Arroyas Sanchez M, et al
    Respiratory outcomes of "new" bronchopulmonary dysplasia in adolescents: A multicenter study.
    Pediatr Pulmonol. 2021;56:1205-1214.
    PubMed     Abstract available


  246. MUIRHEAD CA, Lanocha N, Markwardt S, MacDonald KD, et al
    Evaluation of rescue oral glucocorticoid therapy during inpatient cystic fibrosis exacerbations.
    Pediatr Pulmonol. 2021;56:891-900.
    PubMed     Abstract available


  247. OATES G, Rutland S, Juarez L, Friedman A, et al
    The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.
    Pediatr Pulmonol. 2021;56:883-890.
    PubMed     Abstract available


  248. BEDI PK, DeHaan K, MacLean JE, Castro-Codesal ML, et al
    Predictors of longitudinal outcomes for children using long-term noninvasive ventilation.
    Pediatr Pulmonol. 2021;56:1173-1181.
    PubMed     Abstract available


    January 2021
  249. DU BERRY C, Westrupp N, Shanthikumar S, Welsh L, et al
    Associations between peak oxygen uptake, lung function and bronchiectasis in children with cystic fibrosis in the era of CFTR modulators.
    Pediatr Pulmonol. 2021 Jan 17. doi: 10.1002/ppul.25275.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neonatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: